Screening for the differentially expressed proteins in human gallbladder cancer by two-dimensional gel electrophoresis and mass spectrometry and functional exploration of AnnexinA3

Yi TAN,Hai-ping MENG,Pei-yuan CUI,Zhi-xiang XU,Hao-rong WU

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2010.07.011

2010-01-01

Abstract:Objective To find potential molecular targets for gallbladder cancer diagnostics by analyzing and comparing the proteomes expressed in human gallbladder carcinoma and benign gallbladder tissues, and investigate whether annexinA3 down-regulation by miRNA leads to inhibition of proliferation and arrest of cell cycle in human gallbladder cancer cell line SGC-996. Methods The proteins expressed in these tissues were analyzed by the two-dimensional gel electrophoresis. Proteins expressed differently of a 2-fold change were cut and analyzed by MALDI-TOF/TOF mass spectrometry. After miRNA expression plasmid targeting to annexinA3 gene was constructed and transfected into cancer cells, the methyl thiazolyl tetrazolium ( MTT) assay was performed for measuring cell proliferation and flow cytometic analysis for cell cycle. Results Protein extracts of individual sample in each type of tissues were separated on two-dimensional gels. There were 46 differentially expressed proteins in the tissues of gallbladder cancer. Seventeen proteins were successfully identified by MS, in which 9 proteins were overexpressed in tumors and the rest 8 proteins were underexpressed, including Annexi-nA3, TTR protein, etc. After interfering annexinA3 in gallbladder cancer SGC-996 cell line, the cell proliferation was suppressed. Flow cytometry revealed that after interfering annexinA3 in gallbladder cancer SGC-996 cell line, the cells in G1 phase were increased, while those in S phase were declined as compared with control group (P<0.05). Conclusion Significant discrepancies in protein expression exist between gallbladder cancer tissues and benign gallbladder tissues. Some of the differentially expressed proteins found by the proteomic approach may be potential molecular targets for early diagnosis of gallbladder cancer. miRNA interfering to annexi-nA3 effectively reverses some of the malignant biological characters of gallbladder cancer cells.